Cargando…
Use of sodium glucose co‐transporter 2 inhibitors in acute heart failure: a practical guidance
AIMS: Heart failure (HF) is the most frequent cause of hospital admission among patients 65 years or older. Patients hospitalized for acutely decompensated chronic HF and ‘de novo’ acute heart failure (AHF) continue to experience unacceptably high post‐discharge readmission and mortality rates. METH...
Autores principales: | Ferreira, João Pedro, Pimenta, Joana, Moura, Brenda, Aguiar, Carlos, Franco, Fátima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773770/ https://www.ncbi.nlm.nih.gov/pubmed/36004699 http://dx.doi.org/10.1002/ehf2.14090 |
Ejemplares similares
-
Sodium-Glucose Co-transporter 2 Inhibitors in the Failing Heart: a Growing Potential
por: Brito, Dulce, et al.
Publicado: (2020) -
Evaluating Sodium Restriction in Heart Failure
por: Spineti, Pedro Pimenta de Mello
Publicado: (2019) -
Eligibility of sodium–glucose co‐transporter‐2 inhibitors among patients with diabetes mellitus admitted for heart failure
por: Sharma, Abhinav, et al.
Publicado: (2019) -
Sodium-glucose co-transporter 2 inhibitors in heart failure: an updated evidence-based practical guidance for clinicians
por: Monzo, Luca, et al.
Publicado: (2023) -
The Evolution of Sodium-Glucose Co-Transporter-2 Inhibitors in Heart Failure
por: Fadiran, Olusayo, et al.
Publicado: (2021)